Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies

Research output: Contribution to journalArticlepeer-review

Abstract

This review cites clinical evidence demonstrating that nedocromil sodium can reverse the clinical features of airway inflammation in asthma, as shown by decreased bronchial responsiveness, decreased diurnal variation in peak expiratory flow, improved baseline lung function, and a decrease in the frequency and severity of chronic symptoms. Clinical trials have also shown that nedocromil sodium has a statistically significant and clinically relevant effect on daytime and nighttime asthma symptoms within 3 days of stalling treatment. On an analysis of relevant trials, the effect on asthmatic cough was significant within 24 hours. This rapid effect on symptoms, together with a reversal of the underlying airways inflammation, is a beneficial combination in the management of asthma.

Original languageEnglish (US)
Pages (from-to)S143-S150
JournalJournal of Allergy and Clinical Immunology
Volume98
Issue number5 SUPPL.
DOIs
StatePublished - 1996

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies'. Together they form a unique fingerprint.

Cite this